People channel feed

An ex­o­dus of top Gilead ex­ecs con­tin­ues as new­ly named CMO An­drew Cheng heads for the ex­it

7 years ago

Ex-Pfiz­er ex­ec Geno Ger­mano joins nanopar­ti­cle start­up Elu­ci­da On­col­o­gy as CEO

7 years ago

Roge­rio Vi­val­di jumps from Biover­a­tiv buy­out to lead­ing Flag­ship-seed­ed Sig­ilon's Holy Grail pur­suit

7 years ago

CEO in­ter­rupt­ed: No­var­tis chief Narasimhan looks to new ethics czar to clean up af­ter the lin­ger­ing Co­hen mess

7 years ago
Pharma

Pfiz­er On­col­o­gy los­es its CMO to Al­ler­gan as can­cer ex­ec Charles Hugh-Jones makes a ca­reer leap

7 years ago

In­sid­er trad­ing in Wash­ing­ton: NY Con­gress­man in­dict­ed for shar­ing in­side biotech tips ahead of mas­sive tri­al fail­ure

7 years ago

GSK chief Em­ma Walm­s­ley rounds out her top team with CFO pick — but per­for­mance lags

7 years ago
Bioregnum
Opinion

Tom Hugh­es jumps ship at Zaf­gen and gets back to the helm of a note­wor­thy biotech

7 years ago

No­var­tis on­col­o­gy vet Ste­fan Scher­er joins biotech mi­gra­tion to head clin­i­cal work, CAR-T part­ner­ship at Cel­lec­tis

7 years ago

Genen­tech I/O chief Dan Chen heads to an up­start biotech look­ing to cre­ate a land­mark ad­vance on an­ti­bod­ies

7 years ago
Startups

Big Phar­ma an­a­lyst Tim An­der­son drops off the radar at Bern­stein, head­ed to a new re­search home

7 years ago

Am­gen R&D chief Sean Harp­er hits the ex­its with a one-way tick­et to ear­ly-stage biotech

7 years ago

Help want­ed: New CEO to run Gilead as John Mil­li­gan steps down

7 years ago

Za­vante CEO sells his late-stage an­tibi­ot­ic biotech to Nabri­va — grab­bing the helm in the deal

7 years ago
Pharma

Il­lu­mi­na's found­ing sci­en­tist launch­es soft­ware start­up to track fast-mu­tat­ing hos­pi­tal bugs

7 years ago
Startups

Hu­man Longevi­ty blasts Craig Ven­ter, claim­ing he was fired, then stole trade se­crets — poach­ing staffers for ri­val op­er­a­tion

7 years ago

Bio­gen vet George Scan­gos jumps on the board at up­start MS case man­ag­er Oc­tave, backed by Sec­tion 32

7 years ago
Financing

Genen­tech vet Myr­tle Pot­ter takes a lead­ing role in Vivek Ra­maswamy's fast-mov­ing Vant ops

7 years ago
R&D

Ap­peas­ing ac­tivist in­vestors, Iron­wood cuts 40 staffers at the start of com­pa­ny split

7 years ago
R&D
Pharma

Trump in­vites phar­ma heads to pri­vate din­ner dur­ing Lon­don vis­it, a trip that's in­spir­ing tens of thou­sands to protest

7 years ago
Pharma

Is Mar­tin Shkre­li blog­ging from prison?

7 years ago

'Bio­hack­er' Tray­wick ac­ci­den­tal­ly drowned, of­fi­cial con­firms

7 years ago

Af­ter biotech im­plo­sions, ex-Mil­len­ni­um chief Deb­o­rah Dun­sire is tak­ing the helm at Lund­beck

7 years ago

Sar­co­ma ex­pert George Demetri grades the lat­est state­ment on Nanobi­otix's late-stage drug NBTXR3

7 years ago
R&D
Pharma
First page Previous page 85868788899091 Next page Last page
A service from the Financial Times